Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Enovis Corp

ENOV
Current price
46.38 USD +0.72 USD (+1.58%)
Last closed 45.57 USD
ISIN US1940145022
Sector Industrials
Industry Specialty Industrial Machinery
Exchange NYSE
Capitalization 2 593 740 544 USD
Yield for 12 month -8.79 %
1Y
3Y
5Y
10Y
15Y
ENOV
21.11.2021 - 28.11.2021

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware. Address: 2711 Centerville Road, Wilmington, DE, United States, 19808

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

67.8 USD

P/E ratio

Dividend Yield

Current Year

+1 707 197 000 USD

Last Year

+1 563 101 000 USD

Current Quarter

+505 222 000 USD

Last Quarter

+525 159 999 USD

Current Year

+990 779 000 USD

Last Year

+869 383 000 USD

Current Quarter

+286 459 000 USD

Last Quarter

+247 946 999 USD

Key Figures ENOV

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 296 423 008 USD
Operating Margin TTM 1.15 %
PE Ratio
Return On Assets TTM 0.37 %
PEG Ratio 1.8989
Return On Equity TTM -3.56 %
Wall Street Target Price 67.8 USD
Revenue TTM 2 001 667 968 USD
Book Value 59.61 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 21 %
Dividend Yield
Gross Profit TTM 883 885 000 USD
Earnings per share -2.21 USD
Diluted Eps TTM -2.21 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY 153.1 %
Profit Margin -5.96 %

Dividend Analytics ENOV

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ENOV

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 581:1000
Payout Ratio
Last Split Date 05.04.2022
Dividend Date

Stock Valuation ENOV

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 14.8148
Enterprise Value Revenue 1.9847
Price Sales TTM 1.2958
Enterprise Value EBITDA 22.351
Price Book MRQ 0.7788

Financials ENOV

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ENOV

For 52 weeks

38.27 USD 65.03 USD
50 Day MA 42.23 USD
Shares Short Prior Month 4 240 509
200 Day MA 49.92 USD
Short Ratio 6.34
Shares Short 4 435 072
Short Percent 9.09 %